Iodixanol as a contrast agent in a fibrin hydrogel for endodontic applications by Hertig, Gabriel
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2017
Iodixanol as a contrast agent in a fibrin hydrogel for endodontic applications
Hertig, Gabriel
Abstract: The application of biomaterials used in regenerative endodontics should be traceable. In
this study, we checked some basic effects of rendering a fibrin hydrogel radiopaque using an iodine-based
contrast agent (iodixanol) approved for systemic application. Fibrin hydrogels were prepared from a fibrin
sealant (Tisseel) using either an isotonic iodixanol solution (Visipaque 320, test) or Tris buffer (control) as
a diluent. Gelation kinetics, radiopacity, and swelling of lyophilized hydrogels were tested using standard
methods. Hydrogel structure was evaluated using scanning electron microscopy (SEM). Furthermore,
iodixanol release from the test gels was assessed using spectrophotometry, and tissue compatibility was
compared between test and control hydrogels using the chick chorioallantoic membrane (CAM) assay.
Results were compared using pairwise t-test, p < 0.05. Iodixanol caused a 70-fold delay in gelation
to 26 min in the test compared to the control hydrogels (22 ± 1 s). Radiopacity of the test gels was
1.9 ± 0.2 mm Al/mm, compared to zero in the control hydrogels. Lyophilized hydrogel swelling was
strongly reduced when iodixanol was added to the hydrogel (p < 0.05). Test hydrogels had an altered
SEM appearance compared to controls, and exhibited a reduced porosity. Iodixanol release from the test
hydrogels reached 14.5 ± 0.5% after 120 h and then ceased. This release did not have any apparent toxic
effect and neither affected the viability, nor the physiology or vascularization of the CAM of fertilized
chicken eggs. Iodixanol can render a fibrin hydrogel radiopaque and maintains its tissue compatibility,
yet impacts gelation kinetics and hydrogel porosity.
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-142814
Published Version
 
 
Originally published at:
Hertig, Gabriel. Iodixanol as a contrast agent in a fibrin hydrogel for endodontic applications. 2017,
University of Zurich, Faculty of Medicine.
Universität Zürich 
Zentrum für Zahnmedizin 
Klinik für Mund-, Kiefer- und Gesichtschirurgie 
Direktor: Prof. Dr. med. Dr. med. dent. Martin Rücker 
 
 
 
 
Arbeit unter Leitung von Prof. Dr. med. dent. Matthias Zehnder 
 
 
 
 
 
 
 
 
Iodixanol as a Contrast Agent in a Fibrin Hydrogel 
for Endodontic Applications 
 
 
 
 
 
 
 
INAUGURAL-DISSERTATION 
zur Erlangung der Doktorwürde der Zahnmedizin 
an der Medizinischen Fakultät 
der Universität Zürich 
 
 
 
 
 
 
 
 
vorgelegt von 
Gabriel Hertig 
 
 
 
 
 
 
 
 
Genehmigt auf Antrag von Prof. Dr. rer. nat. Franz E. Weber 
Zürich 2017  
Publikationshinweis 
 
 
Iodixanol as a Contrast Agent in a Fibrin Hydrogel for Endodontic Applications 
 
 
 
Publiziert am: 15. März 2017 
 
 
Journal: Frontiers in Physiology, Craniofacial Biology and Dental 
Research  
https://doi.org/10.3389/fphys.2017.00152  
  
ORIGINAL RESEARCH
published: 15 March 2017
doi: 10.3389/fphys.2017.00152
Frontiers in Physiology | www.frontiersin.org 1 March 2017 | Volume 8 | Article 152
Edited by:
David P. Rice,
University of Helsinki, Finland
Reviewed by:
Jean-Christophe Farges,
Claude Bernard University Lyon 1,
France
Aránzazu Díaz-Cuenca,
Consejo Superior de Investigaciones
Científicas (CSIC), Spain
*Correspondence:
Matthias Zehnder
matthias.zehnder@zzm.uzh.ch
Specialty section:
This article was submitted to
Craniofacial Biology and Dental
Research,
a section of the journal
Frontiers in Physiology
Received: 11 January 2017
Accepted: 27 February 2017
Published: 15 March 2017
Citation:
Hertig G, Zehnder M, Woloszyk A,
Mitsiadis TA, Ivica A and Weber FE
(2017) Iodixanol as a Contrast Agent
in a Fibrin Hydrogel for Endodontic
Applications. Front. Physiol. 8:152.
doi: 10.3389/fphys.2017.00152
Iodixanol as a Contrast Agent in a
Fibrin Hydrogel for Endodontic
Applications
Gabriel Hertig 1, Matthias Zehnder 2*, Anna Woloszyk 3, Thimios A. Mitsiadis 3, Anja Ivica 1
and Franz E. Weber 1
1Oral Biotechnology and Bioengineering, University of Zurich, Zurich, Switzerland, 2 Preventive Dentistry, Periodontology, and
Cariology, University of Zurich, Zurich, Switzerland, 3Orofacial Development and Regeneration, Institute of Oral Biology,
University of Zurich, Zurich, Switzerland
The application of biomaterials used in regenerative endodontics should be traceable. In
this study, we checked some basic effects of rendering a fibrin hydrogel radiopaque
using an iodine-based contrast agent (iodixanol) approved for systemic application.
Fibrin hydrogels were prepared from a fibrin sealant (Tisseel) using either an isotonic
iodixanol solution (Visipaque 320, test) or Tris buffer (control) as a diluent. Gelation
kinetics, radiopacity, and swelling of lyophilized hydrogels were tested using standard
methods. Hydrogel structure was evaluated using scanning electron microscopy (SEM).
Furthermore, iodixanol release from the test gels was assessed using spectrophotometry,
and tissue compatibility was compared between test and control hydrogels using the
chick chorioallantoic membrane (CAM) assay. Results were compared using pairwise
t-test, p < 0.05. Iodixanol caused a 70-fold delay in gelation to 26min in the test
compared to the control hydrogels (22 ± 1 s). Radiopacity of the test gels was 1.9 ± 0.2
mm Al/mm, compared to zero in the control hydrogels. Lyophilized hydrogel swelling was
strongly reduced when iodixanol was added to the hydrogel (p < 0.05). Test hydrogels
had an altered SEM appearance compared to controls, and exhibited a reduced porosity.
Iodixanol release from the test hydrogels reached 14.5 ± 0.5% after 120 h and then
ceased. This release did not have any apparent toxic effect and neither affected the
viability, nor the physiology or vascularization of the CAM of fertilized chicken eggs.
Iodixanol can render a fibrin hydrogel radiopaque and maintains its tissue compatibility,
yet impacts gelation kinetics and hydrogel porosity.
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INTRODUCTION
An exciting new field has emerged in endodontic research over the recent years: Regenerative
Endodontics (Hargreaves, 2016). While attempts to attract soft tissues into the necrotic root canal
space are not necessarily new (Nygaard Ostby, 1963), the systematic approach in the context
of current tissue engineering concepts surely is. Different paths are followed that vary from
pure basic science to translational medicine with the development and improvement of clinically
applicable protocols. However, the passage to the clinics necessitates specific precautions for tissue
engineering concepts and related products (Mao et al., 2012). These include issues such as treatment
costs, safety, and also the regulation of medical devices by local administrative bodies.
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Currently, in the context of pulp tissue engineering, a so-called
cell-free or cell-homing approach is seen as favorable (Kim et al.,
2010; Lee et al., 2010). This approach involves the conditioning
of the root canal wall by EDTA to release molecular cues for
the attraction and differentiation of invading pluripotent cells,
followed by the application of a scaffold in the pulp space (Galler,
2016). In the current clinical protocol, this scaffold is a blood
clot, which is generated by controlled bleeding through the apical
foramen (Trope, 2010). Clinical outcomes with this technique
vary (Chen et al., 2012), and negative reports have curbed the
initial enthusiasm (Nosrat et al., 2012). Discoloration of the
crown is a frequent observation, and continued growth of the
root is not predictably achieved (Kahler et al., 2014; Simon et al.,
2014).
The procedure of “controlled bleeding” per se is problematic
from a clinical point of view,mainly for two reasons: Hemorrhage
has a negative effect on tooth color (Marin et al., 1997),
and the whole procedure and its state-of-the-art execution
are hard if not impossible to be monitored. Proper case
documentation, however, is the core of good clinical practice.
Recent approaches to replace the controlled bleeding step in
regenerative endodontics involved the application of a fibrin
hydrogel into the empty pulp space in order to create a synthetic,
non-staining blood clot (Ruangsawasdi et al., 2014). The fibrin
hydrogel could be placed in a controlled manner using a micro-
cannula or a lentulo spiral. However, it would be desirable
to obtain a radiopaque hydrogel for better controlling and
monitoring of the procedure. In the current study we investigated
the effects of a biocompatible iodinated X-ray contrast agent
systemically used in angiography on some basic properties of a
fibrin hydrogel intended for endodontic applications.
MATERIALS AND METHODS
Preparation of Hydrogels
Hydrogels were prepared from a commercially available fibrin
sealant (Tisseel, Baxter; Deerfield, IL). The two components of
the sealant were diluted to obtain a control fibrin hydrogel as
previously described (Ruangsawasdi et al., 2017). To prepare the
control hydrogels, the thrombin component and the fibrinogen
component were diluted in Tris-buffered saline (TBS) and then
mixed as described below. In the test hydrogels, the TBS was
replaced by an aqueous isotonic contrast agent (Visipaque 320,
GE Healthcare, Cork, Ireland) containing 652mg of iodixanol
per mL of liquid, which equals 320 mg/mL of iodine. The pH
of the two solutions was measured using a calibrated electrode
(Metrohm, Herisau, Switzerland). The pH of TBS was 7.6, while
the pH of Visipaque 320 equaled 7.1.
Gelation Kinetics
Fibrin hydrogels gelate via fibrin clotting. Clotting time was
tested according to the method described by Vermylen et al.
(1963). The two hydrogel components were prepared separately
in micro-centrifugation tubes in a water bath at 37◦C. For 250µL
of the thrombin solution 2 µL of thrombin were added to 248 µL
of TBS or Visipaque; 250µL of fibrinogen solution were prepared
by adding 44 µL of fibrinogen to 206 µL of TBS or Visipaque.
Pre-warmed thrombin solution was transferred to the fibrinogen
counterpart using this pipette. The agents were mixed using a
pipette. The micro-centrifugation tubes were kept in the water
bath at 37◦C during the whole experiment. A platinum loop was
moved in and out of the clotting mixture until the appearance of
the fibrin web, which marked the end point (hydrogelation). The
time to reach this point was recorded using a stopwatch. These
experiments were performed in triplicates with freshly prepared
solutions.
Assessment of Radiopacity
Test and control hydrogels were filled into polycarbonate molds
10 mm in diameter and 1 mm thick. Three molds were
filled per experiment. Slices with a thickness of 1 mm from
the crowns of bovine teeth served as control for the clear
distinction between material and the surrounding tissue in
clinical situations. Specimens were placed on a radiographic
sensor (Digora, Soredex, Tuusula, Finland) together with an
aluminum step-wedge with a thickness from 0.5 to 6mm (0.5 and
1 mm increments, Figures 1a,b). A Trophy Irix (Trophy, Paris,
France) X-ray unit operating at 65 kV, 8 mA, and 0.22 s with a
focus-film distance of 25 cm was used. Hydrogels were prepared
immediately prior to use. These triplicate measurements were
performed three times each with freshly prepared hydrogels.
Digital radiographic images were imported with the Digora
system, using Digora software version 1.51 for Windows without
gray scale correction. Optimas image analysis software (Meyer
Instruments Inc., Houston, TX) was used to determine the gray
value of the samples and convert these to mm of aluminum
equivalent (mm Al). To assess the relative radiopacity of
the test fibrin hydrogel in human teeth, the root canals of
premolars extracted for orthodontic reasons were prepared using
FIGURE 1 | Digital radiographs of the test (a,c) and the control fibrin
hydrogel (b) under investigation. A cross-section of a human incisor crown
was used as a reference. A photograph of the set-up is depicted in the insert.
The aluminum step-wedge had a thickness of 0.5, 1, 1.5, 2, and then 3 mm
Al, followed by 1 mm steps. As can be appreciated from this figure, the test
hydrogel (a) had a radiopacity of ∼2 mm Al/mm, whilst the control hydrogel
(b) displayed no radiopacity (dotted lines). Freshly mixed test hydrogel
containing iodixanol was placed in the root canal system of immature human
premolars using a lentulo spiral (c). This test hydrogel apparently filled the
whole canal space and could be clearly discerned from root dentin.
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the ProTaper system (Sirona Dentsply Endodontics, Ballaigues,
Switzerland) and filled with freshly mixed hydrogel using a
lentulo spiral. The teeth were radiographed as described above.
Swelling of Hydrogels
The water-absorbing capacity (swelling) was calculated
gravimetrically according to the formula:
Swelling ratio = (ws − wd)/wd
where ws is the weight of the swollen hydrogel and wd is the
weight of the dry hydrogel. The hydrogels were prepared with
TBS or Visipaque, frozen at −80◦C overnight and freeze-dried
under vacuum for 24 h until constant weight in a lyophilization
apparatus (Christ, Osterode am Harz, Germany). The dry
hydrogels were pre-weighed in a precision balance (PE360;
Mettler Toledo, Greifensee, Switzerland) and were immersed in
5 mL of TBS at 37◦C for 5 min, 1, 8, and 24 h. After removing
them from the TBS at each time point, the hydrogels were gently
wiped with a filter paper and weighted again. Subsequently, the
hydrogels were immersed in fresh TBS. The swelling ratio was
measured by comparing the weight of hydrogels before and after
immersing in TBS according to the equation. These experiments
were performed in triplicates.
Scanning Electron Microscopy
To visualize the microstructure of the test and the control
hydrogels under investigation, triplicates of lyophilized
specimens were inspected using scanning electron microscopy
(SEM). To this end, the freeze-dried hydrogels were attached
to sticky carbon pads (Plano, Wetzlar, Germany) on SEM
pin stubs. Specimens were sputtered with an 8 nm gold layer
(Safematic, Bad Ragaz, Switzerland). Images were obtained at
5 mV acceleration voltage and 12 mm working distance using
a secondary electron detector (Zeiss Supra 50VP, Oberkochen,
Germany).
Release of Iodixanol from Test Hydrogels
The UV spectrum of an iodixanol solution in water shows a
maximum at 244 nm and a specific absorption coefficient of 320
l g−1 cm−1 at that wavelength (Schroder et al., 1997). To test the
release of iodixanol from the test hydrogels, 1 mL of hydrogel was
mixed with 49 mL of TBS in 50 mL polypropylene centrifugation
tubes (Falcon, Thermo Fisher Scientific, Waltham, MA). These
tubes were rotated at room temperature (25◦C) at 6 rpm in
an overhead rotator with a radius of 10 cm (Bibby Scientific,
Staffordshire, UK). 100 µL of the solution were removed (and
not replenished) to be assessed spectrophotometrically for their
iodixanol content after 30 min, 1, 3, 8, 24, 48, 72, 120, and finally
after 168 h. Experiments were done in triplicates. Iodixanol that
washed out from the hydrogel was quantified at 244 nm in a
spectrophotometer (Shimadzu, Kyoto, Japan) in quartz cuvettes
against a standard curve. Iodixanol wash out is presented as % of
total iodixanol originally present in the hydrogel in solution.
Chick Chorioallantoic Membrane (CAM)
Assay
CAM assays were performed to assess the impact of test and
control hydrogels on tissue viability and vascularization of
fertilized chicken eggs (Beckers et al., 1997). A total of 14
fertilized Lohmanwhite LSL chicken eggs (Animalco AG, Staufen
AG, Switzerland) were used for these experiments, seven in the
control and seven in the test hydrogel group. According to the
local animal care guidelines (Canton of Zurich, Switzerland),
no approval was necessary to perform these experiments, as
they were executed only until embryonic day (ED) 14. Detailed
procedures have been published (Woloszyk et al., 2016). Eggs
were pre-incubated for 3 days at 38◦C at a rotational speed
of 360◦/4 h (Bruja 3,000, Brutmaschinen-Janeschitz GmbH,
Hammelburg, Germany). On ED 3, the eggs were processed for
in ovo cultivation. The eggshell was wiped with 70% ethanol.
To lower the developing embryo before opening of the shell
using Scotch tape and scissors, 4 mL of albumen were removed
through a small hole in the shell. The egg was stabilized in a 60
mm Petri dish base. The opening was covered with a second 60
mm Petri dish base, which was fixed to the bottom base using
Scotch tape. Subsequently, the eggs were incubated at 37◦C. On
ED 7, hydrogel samples polymerized within a silicone O-ring
(from Corning cryogenic vials, Sigma-Aldrich, St. Louis, MO)
were gently placed on the CAM (1 per egg), and the eggs were
incubated for further 7 days until ED 14. One egg in the test
and one in the control group did not survive the 7 days pre-
incubation, leaving 6 viable eggs in the control and the test group,
respectively. On ED 14, the hydrogel probes together with the
CAM were cut out and after fixing in 4% paraformaldehyde for
60 min at room temperature, the probes were washed and stored
in PBS. Pictures were taken using a stereomicroscope (Leica
Microsystems AG, Heerbrugg SG, Switzerland). Vascularization
within the silicone O-ring was quantified on these images using
ImageJ v1.50b.
Data Presentation
Numerical data is presented as means and standard deviations.
Pair-wise comparisons between the test and the control hydrogel
were performed using paired t-test. The alpha-type error was set
at 5% (p< 0.05).
RESULTS
The control fibrin hydrogel prepared with TBS clotted quickly.
The recorded mean gelation time was 22 ± 1 s. Gelation
was strongly delayed by the presence of iodixanol; it occurred
after 1,580 ± 75 s (p < 0.05), i.e., 26 min. The iodixanol
solution (Visipaque) rendered the test hydrogel radiopaque with
a mean radiopacity of 1.9 ± 0.2 mm Al/mm. The test hydrogel
could clearly be distinguished from root dentin of human teeth
radiographically (Figures 1a,c), while the control hydrogel had
no detectable radiopacity (Figure 1b).
Results showed that swelling was strongly reduced when
iodixanol was added to the hydrogel. Values decreased from
203% for control hydrogels prepared with TBS to only
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FIGURE 2 | Swelling of lyophilized hydrogels. Panel (a) presents the swelling ratio of lyophilized fibrin hydrogels prepared with TBS (control) and the iodixanol
solution (Visipaque) after different time of incubation in TBS at 37◦C, showing that iodixanol reduced the water sorption of hydrogel. As time passed, the amount of
retained water in the test hydrogel decreased and caused the shrinking of the hydrogel structure. Panel (b) is a typical SEM image of the control hydrogel, panel (c) a
corresponding image of the test hydrogel containing iodixanol.
8% for counterparts prepared with Visipaque (time point 5
min, p < 0.05) (Figure 2a). Inspection of the lyophilized
hydrogels in a scanning electron microscope confirmed that
iodixanol influenced their structure. While the control hydrogel
showed the typical sponge-like porous structure (Figure 2b),
the test hydrogel containing iodixanol had a more homogenous
appearance with few internal openings (Figure 2c).
Iodixanol release from the hydrogels prepared with Visipaque
reached 14.5 ± 0.5% after 120 h and then ceased (Figure 3).
This release from test hydrogels did not have any apparent
effect on the fertilized chicken eggs. All incubated eggs survived
the exposure to either the test or the control hydrogel
between embryonic day 7 and 14, and vascularization in the
chorioallantoic membrane under the hydrogels looked similar
(Figure 4). Quantification of the vascularization revealed no
statistically significant difference between groups (p= 0.34).
DISCUSSION
This study showed that a radiopaque and tissue-compatible,
yet slow setting and less porous fibrin hydrogel is obtained by
FIGURE 3 | Iodixanol release from test fibrin hydrogels. One milliliter was
suspended in 49mL of tris-buffered saline (TBS) over time, expressed in % of
the total iodixanol that was present in the hydrogel initially.
diluting a commercially available fibrin sealant with an isotonic
contrast agent containing iodixanol rather than TBS. Basic
properties of this experimental hydrogel such as hydrogelation
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FIGURE 4 | Chick chorioallantoic membrane (CAM) assay used in this study (left). Control fibrin hydrogels (upper row) and radiopaque test counterparts
spiked with iodixanol (lower row) were placed in o-rings on the CAM for 7 days (from embryonic day 7 to 14), and vascularization was quantified. There was no
difference between the test and the control group.
kinetics, radiopacity, swelling, iodixanol release, and overall
tissue compatibility were assessed. The current in vitro and in
ovo results are preliminary observations and should be seen
as such. At this point, it is not possible to draw conclusions
regarding the suitability of the test hydrogel for pulp tissue
engineering.
The fibrin sealant used in this study (Tisseel), which is
designed to achieve hemostasis, to seal or glue tissue, and to
support wound healing, has to be diluted in TBS to obtain a
fibrin hydrogel that could be invaded by cells during the pulp
regeneration process (Ruangsawasdi et al., 2014). This creates
an opportunity to replace the TBS used for that purpose with
a similar, isotonic product having enhanced contrast properties
(Visipaque 320). Opacity of hydrogels by addition of the
iodixanol that is contained in Visipaque has recently been tested
in chitosan hydrogels for controlled blood vessel embolization
(Fatimi et al., 2016). Iodixanol extends blood-clotting time
(Bellemain-Appaix et al., 2012), which is concurrent with the
results obtained here using a fibrin sealant. It is a non-ionic dimer
(Jones and Goodall, 2003). In the current approach, we chose
iodixanol because alternative contrast agents such as the non-
ionic monomer iohexol (Omnipaque, Bayer Pharma AG, Berlin,
Germany) and the ionic dimer ioxaglate (Hexabrix, Guerbet,
Roissy, France) appear to have an even higher anticoagulant
effect than iodixanol (Corot et al., 1996). It has also been
shown that the slowing of the hydrogelation process in chitosan
hydrogels by iodixanol is dose-dependent (Fatimi et al., 2016).
Since teeth are inherently radiopaque structures, we used a high
concentration of iodixanol compared to previous experiments on
chitosan hydrogels for embolization. However, the radiopacity of
permanent sealing materials requested by the ISO norm (2012),
which is 3 mm Al/mm, was still not met. Nevertheless, the
preliminary filling experiments with human teeth showed that
the radiopacity should be sufficient for the intended purpose, i.e.,
the monitoring of the correct placement of the fibrin hydrogel
(Figure 1c).
The extended clotting time, which resulted from the presence
of iodixanol in the fibrin hydrogel, can be desirable in endodontic
applications. The radiopaque fibrin hydrogel under investigation
has a working time similar to endodontic sealers (Whitworth,
1999). It can be applied into the root canal system using
for example a lentulo spiral. In contrast, the mere fibrin
hydrogel diluted with TBS, which is commonly used as a
control (Ruangsawasdi et al., 2014, 2017), is not easy to
administer into the root canal system because of its immediate
gelation.
The swelling of hydrogels is related to the crosslinking ratio
in their polymeric network. Highly cross-linked hydrogels tend
to swell less than counterparts with a lower crosslinking ratio
(Peppas et al., 2000). The effect of iodixanol on swelling of
lyophilized hydrogels and on the apparent hydrogel structure
in SEM scans strongly suggests that hydrogel porosity is
reduced. This is in line with previous studies showing reduction
of chitosan hydrogel swelling by increasing their iodixanol
concentration (Fatimi et al., 2016). The addition of iodixanol to
fibrin-rich clots resulted in shorter, thinner, and more numerous
fibrin fibers when compared to counterparts made with ioxaglate
or buffer, leading to a much more compact 3D architecture with
smaller pores and higher crosslinking of fibrin fibers (Bellemain-
Appaix et al., 2012). Furthermore, there was an apparent negative
swelling after 5 min with the test hydrogel under the current
conditions. This might be indicative of a material degradation
process. The iodixanol modified hydrogels hardly took up any
TBS fluid, suggesting an important loss of hydrophilicty or
material permeability. Both are important characteristics for a
biomaterial scaffold in regenerative procedures. Incorporation of
iodixanol seems to produce a fiber coalescence process leading
to a tensional film-like morphology (Figure 2). It thus remains to
be investigated how these iodixanol-induced alterations influence
the permeability of fibrin hydrogels to migrating cells during
regenerative processes.
We used the CAM assay as a measure of tissue compatibility
of the new radiopaque hydrogel under investigation. Although
this assay is relatively simple, it can be considered suitable
for the pre-screening of scaffolds to determine whether they
cause any adverse tissue reactions (Baiguera et al., 2012). Our
results suggest good tissue compatibility of the test as well
as the control hydrogel. However, it needs to be cautioned
that the CAM assay is a non-mammalian organism that has
not yet developed an immune system. This assay merely
Frontiers in Physiology | www.frontiersin.org 5 March 2017 | Volume 8 | Article 152
Hertig et al. Iodixanol in a Fibrin Hydrogel for Endodontic Applications
determined the effect of the fibrin hydrogels on tissue viability
and vascularization. Histological assessment of the hydrogels
revealed that no blood vessels grew into the body of the hydrogels
(data not shown). This is to be expected, as we did not embed
any chemotactic molecules into the hydrogels (Anderson et al.,
2011).
In conclusion, the current results revealed the possibility to
elaborate radiopaque fibrin hydrogels for potential endodontic
applications from materials that are already commercially
available. Under the current conditions, tissue compatibility
appeared not to be influenced by the addition of iodixanol to
the hydrogel. Further in vivo studies should test the effects of
different contrast agents on fibrin hydrogel structure combined
with cell migration and attraction.
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